155
Views
14
CrossRef citations to date
0
Altmetric
Reviews

The cladribine conundrum: deciphering the drug's mechanism of action

, ScD (Professor) & , PhD (Vice President and Scientific Director)
Pages 75-81 | Published online: 07 Dec 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

PaulaX. Fernández-Calotti, Dolors Colomer & Marçal Pastor-Anglada. (2011) Translocation of Nucleoside Analogs Across the Plasma Membrane in Hematologic Malignancies. Nucleosides, Nucleotides & Nucleic Acids 30:12, pages 1324-1340.
Read now

Articles from other publishers (13)

Elina Järvinen, Fumi Suomi, James B Stewart, Dimitri Guala, Miko Valori, Lilja Jansson, Janne Nieminen, Thomas G McWilliams & Pentti J Tienari. (2023) Cultured lymphocytes’ mitochondrial genome integrity is not altered by cladribine. Clinical and Experimental Immunology.
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism 69 105 .
Jesús Quezada‐Vidal, Rocío Ortíz‐Muñiz, Elsa Cervantes‐Ríos, Virginia Cruz‐Vallejo & Pedro Morales‐Ramírez. (2020) In vivo kinetics of the genotoxic and cytotoxic activities of cladribine and clofarabine. Environmental and Molecular Mutagenesis 61:9, pages 922-927.
Crossref
Virginia Cruz‐Vallejo, Rocío Ortíz‐Muñiz, Teresita Vallarino‐Kelly, Elsa Cervantes‐Ríos & Pedro Morales‐Ramírez. (2019) In vivo Characterization of the Radiosensitizing Effect of a Very Low Dose of BrdU in Murine Cells Exposed to Low‐Dose Radiation . Environmental and Molecular Mutagenesis.
Crossref
Emma D. Deeks. (2018) Cladribine Tablets: A Review in Relapsing MS. CNS Drugs 32:8, pages 785-796.
Crossref
Gavin Giovannoni. (2017) Cladribine to Treat Relapsing Forms of Multiple Sclerosis. Neurotherapeutics 14:4, pages 874-887.
Crossref
Tabetha Sundin, Dennis M. Peffley, David Gauthier & Patricia Hentosh. (2012) The isoprenoid perillyl alcohol inhibits telomerase activity in prostate cancer cells. Biochimie 94:12, pages 2639-2648.
Crossref
Kyle Jensen, L’Aurelle A. Johnson, Pamala A. Jacobson, Sonja Kachler, Mark N. Kirstein, Jatinder Lamba & Karl-Norbert Klotz. (2012) Cytotoxic purine nucleoside analogues bind to A1, A2A, and A3 adenosine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 385:5, pages 519-525.
Crossref
Tokumi Maruyama, Norikazu Sakakibara & Ai Kakoh. (2012) First Synthesis of [6-15N]-Cladribine Using Ribonucleoside as a Starting Material. HETEROCYCLES 85:1, pages 171.
Crossref
Bruno Laugel, Frédéric Borlat, Laurent Galibert, Alain Vicari, Robert Weissert, Yolande Chvatchko & Denis Bruniquel. (2011) Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity. Journal of Neuroimmunology 240-241, pages 52-57.
Crossref
Gavin Giovannoni & Stuart D. Cook. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 358 369 .
. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 300 582 .
Ekaitz Errasti-Murugarren & Marçal Pastor-Anglada. (2010) Drug transporter pharmacogenetics in nucleoside-based therapies. Pharmacogenomics 11:6, pages 809-841.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.